GRIFOLS SA INH. A EO-,25/ ES0171996087 /
| 2024-06-05 5:26:26 PM | Chg. +0.17 | Volume | Bid8:04:50 PM | Ask8:04:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.52EUR | +1.86% | 9,017 Turnover: 85,723.10 |
9.38Bid Size: 560 | 9.48Ask Size: 550 | 7.85 bill.EUR | - | 105.76 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...
